secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quince Therapeutics, Inc. (QNCX)
CIK:        0001662774
Form:       8-K
Filed at:   2024-11-14T23:59:59+00:00
Accession:  0001662774-24-000013
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Quince Therapeutics regains Nasdaq minimum bid price compliance; delisting risk removed
--------------------------------------------------------------------------------

- On Nov 12, 2024, Nasdaq confirmed Quince regained compliance with $1.00 minimum bid price rule.
- Compliance achieved after closing bid price stayed at or above $1.00 for 10 consecutive business days (Oct 29–Nov 11, 2024).
- This resolves the non-compliance notice received June 20, 2024, and the matter is closed.
- The company was facing potential delisting from Nasdaq Global Select Market if not compliant by Dec 17, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662774/000166277424000013/0001662774-24-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662774/000166277424000013/qncx-20241112.htm
  HTML page:      https://secwatch.observer/filing/0001662774-24-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer